US Drug Recall Register

FDA Drug Recalls

1,709 recalls · Class III, newest first

Class III · Low risk Terminated

Bronkaid Dual Action Formula

Reason Labeling: Label lacks warning or Rx legend; Certain information was inadvertently excluded from the product carton label.

Bayer Healthcare, LLC D-177-2013
Class III · Low risk Terminated

Clean & Clear advantage

Reason Superpotent (Single Ingredient Drug): salicylic acid

Johnson & Johnson NDC 58232-0326-8 D-098-2013
Class III · Low risk Terminated

Carisoprodol Tablets

Reason Labeling: Not elsewhere classified: On 12/12/11, DEA published a final rule in the Federal Register making this product a schedule IV (C-IV)controlled substance. This product is being recalled because this controlled product was not relabeled with the required "C-IV" imprint on the label for products distributed after the 06/11/12 deadline.

West-ward Pharmaceutical Corp. NDC 0143-1176-01 D-201-2013
Class III · Low risk Terminated

TORISEL Kit

Reason Lack of Assurance of Sterility; potential that a low level of endotoxins may be present in the diluent vials.

Pfizer Inc. NDC 0008-1179-01 D-219-2013
Class III · Low risk Terminated

Derma-Smoothe/FS

Reason Subpotent; 22 month stability timepoint

Hill Dermaceuticals, Inc. NDC 28105-149-04 D-218-2013
Class III · Low risk Terminated

Derma-Smoothe/FS

Reason Subpotent; 12 month stability timepoint

Hill Dermaceuticals, Inc. NDC 28105-150-04 D-217-2013
Class III · Low risk Terminated

EstroGel

Reason Defective Container: Pump head detaching from the canister unit upon removal of the overcap.

Ascend Therapeutics Inc D-146-2013
Class III · Low risk Terminated

Advair HFA

Reason Product Lacks Stability: These lots are being recalled due to the failure to meet the particle size distribution specification.

GlaxoSmithKline, LLC. NDC 0173-0715-22 D-065-2013
Class III · Low risk Terminated

Advair HFA

Reason Product Lacks Stability: These lots are being recalled due to the failure to meet the particle size distribution specification.

GlaxoSmithKline, LLC. NDC 0173-0715-20 D-064-2013
Class III · Low risk Terminated

ESTEE LAUDER DayWear Sheer Tint Release

Reason Failed Stability Specifications: The active sunscreen ingredient, avobenzone 3%, may not be stable over the shelf life, the sunscreen effectiveness may be less than labeled.

Estee Lauder Inc NDC 11559-008-01 D-151-2013
Class III · Low risk Terminated

AcneFree Acne Pore Cleanser

Reason Subpotent (Single Ingredient) Drug: This product was found to be subpotent for the benzoyl peroxide active ingredient. Additionally, this product is mislabeled because the label either omits or erroneously added inactive ingredients to the label.

Valeant Pharmaceuticals D-049-2013
Class III · Low risk Terminated

AcneFree Severe Maximum Strength Acne Pore Cleanser

Reason Subpotent (Single Ingredient) Drug: This product was found to be subpotent for the benzoyl peroxide active ingredient. Additionally, this product is mislabeled because the label either omits or erroneously added inactive ingredients to the label.

Valeant Pharmaceuticals D-048-2013
Class III · Low risk Terminated

AcneFree 3-in-1 Acne Night Repair Foam

Reason Subpotent (Single Ingredient) Drug: This product was found to be subpotent for the salicylic acid ingredient. Additionally, this product is mislabeled because the label either omits or erroneously added inactive ingredients to the label.

Valeant Pharmaceuticals D-047-2013
Class III · Low risk Terminated

AcneFree Acne Astringent Toner Pads

Reason Subpotent (Single Ingredient) Drug: This product was found to be subpotent for the salicyclic acid active ingredient.

Valeant Pharmaceuticals D-046-2013
Class III · Low risk Terminated

AcneFree Original Strength Terminator

Reason Subpotent (Single Ingredient) Drug: This product was found to be subpotent for the benzoyl peroxide active ingredient. Additionally, this product is mislabeled because the label either omits or erroneously added inactive ingredients to the label.

Valeant Pharmaceuticals D-045-2013
Class III · Low risk Terminated

AcneFree Oil-Free Acne Cleanser

Reason Subpotent (Single Ingredient) Drug: This product was found to be subpotent for the benzoyl peroxide active ingredient. Additionally, this product is mislabeled because the label either omits or erroneously added inactive ingredients to the label.

Valeant Pharmaceuticals D-044-2013
Class III · Low risk Terminated

AcneFree 24 Hour Severe Acne Clearing System containing 1-count 4 fl oz

Reason Subpotent (Single Ingredient) Drug: This product was found to be subpotent for the benzoyl peroxide active ingredient. Additionally, this product is mislabeled because the label either omits or erroneously added inactive ingredients to the label.

Valeant Pharmaceuticals D-043-2013
Class III · Low risk Terminated

AcneFree 24 Hour Clearing System containing 1-count 4 fl oz

Reason Subpotent (Single Ingredient) Drug: This product was found to be subpotent for the benzoyl peroxide active ingredient. Additionally, this product is mislabeled because the label either omits or erroneously added inactive ingredients to the label.

Valeant Pharmaceuticals D-042-2013
Class III · Low risk Terminated

Lemon Hand Sanitizing Wipes

Reason CGMP Deviations: The products were manufactured with raw material which contain unknown particles believed to be water and dirt.

ITW Dymon D-056-2013
Class III · Low risk Terminated

CellCept

Reason Short Fill: some bottles contained less than 120-count per labeled claim.

Genentech, Inc. NDC 0004-0259-05 D-097-2013
Class III · Low risk Terminated

Children's Cetirizine HCl Chewable Tablets 5 mg

Reason Impurity/Degradation; exceeded impurity specification at the 8 and 15 month time points (betacyclodextrin ester 1&2)

Sandoz Incorporated NDC 0781-5283-64 D-008-2013
Class III · Low risk Terminated

Pramipexole Dihydrochloride Tablets

Reason Impurities/Degradation Products: An out of specification result for a known impurity of the product occurred during 12 month stability testing.

Sandoz Incorporated NDC 0781-5248-92 D-1678-2012
Class III · Low risk Terminated

Pramipexole Dihydrochloride Tablets

Reason Impurities/Degradation Products: An out of specification result for a known impurity of the product occurred during 12 month stability testing.

Sandoz Incorporated D-1677-2012
Class III · Low risk Terminated

Enalapril Maleate Tablet

Reason Labeling Illegible: Some bottles labels have incomplete NDC numbers and missing strength.

Apace KY LLC NDC 15338-211-30 D-1683-2012
Class III · Low risk Terminated

Novarel¿

Reason Labeling; incorrect or missing insert; Warnings portion of the Package Insert is missing the warning statement: Anaphylaxis has been reported with urinary-derived hCG products.

Ferring Pharmaceuticals Inc NDC 55566-1501-0 D-073-2013